Skip to main content
. Author manuscript; available in PMC: 2014 Aug 15.
Published in final edited form as: Nature. 2013 Oct 30;503(7475):277–280. doi: 10.1038/nature12746

Extended Data Figure 4.

Extended Data Figure 4

BAL CD4+ T cells in five chronically SHIV infected macaques treated with two anti-HIV 1 neutralizing mAbs. Plasma viral loads and the % CD4+ T cells in CD3+ gated BAL specimens, prior to (first 1100 to 1140 days) and during the first or second cycle of combination mAb treatment, are shown.